Common Pitfalls in Reporting the Use of SPSS Software
Mohamed A. Gouda(The University of Texas MD Anderson Cancer Center)
Cited by 60
Related Papers
Liquid Biopsy Response Evaluation Criteria in Solid Tumors (LB-RECIST)
|Annals of Oncology|2023|103
Precision oncology for BRAF-mutant cancers with BRAF and MEK inhibitors: from melanoma to tissue-agnostic therapy
|ESMO Open|2023|101
Expanding the Benefit: Dabrafenib/Trametinib as Tissue-Agnostic Therapy for <i>BRAF</i> V600E–Positive Adult and Pediatric Solid Tumors
|American Society of Clinical Oncology Educational Book|2023|92
ALK fusions in the pan-cancer setting: another tumor-agnostic target?
|npj Precision Oncology|2023|89
The evolving landscape of tissue‐agnostic therapies in precision oncology
|CA A Cancer Journal for Clinicians|2024|68